Cite

HARVARD Citation

    Wang, H. et al. (2018). Mutation abundance affects the therapeutic efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma: A retrospective analysis. Cancer biology & therapy. 19 (8), pp. 687-694. [Online]. 
  
Back to record